Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_assertion type Assertion NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_head.
- NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_assertion description "[To develop diagnostic tools with greater specificity for ovarian cancers, the present study was targeted at characterizing the biosynthetic capacity of the epithelial ovarian cancer cell lines from the American Type Culture Collection with respect to inhibin, activin, the related activin-binding protein follistatin (FS), and activin receptor type II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_provenance.
- NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_assertion evidence source_evidence_literature NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_provenance.
- NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_assertion SIO_000772 8593793 NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_provenance.
- NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_assertion wasDerivedFrom befree-20150227 NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_provenance.
- NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_assertion wasGeneratedBy ECO_0000203 NP953503.RAmPN3yq_LomBFDmWR4vWZU_i2_wbzOPIJtyJPxeick1I130_provenance.